An Act Requiring Health Insurance Coverage For Diagnostic And Screening Colonoscopies.
Summary
HB 5174 would amend Connecticut’s insurance statutes to require individual and group health insurance policies to cover diagnostic and screening colonoscopies with no out-of-pocket cost to the insured. The bill also extends that zero-cost coverage requirement to any medically necessary preparation for the procedure when recommended by a health care provider acting within the scope of practice.
In practical terms, the measure is aimed at removing cost-sharing barriers for colonoscopy services, whether the procedure is preventive screening or diagnostic follow-up. By specifying both the colonoscopy itself and related preparation, the bill seeks to ensure that patients do not face deductibles, copayments, coinsurance, or other direct charges for these services under covered health plans.
Impact
The bill would amend chapter 700c of the Connecticut General Statutes, expanding mandated health insurance benefits for both individual and group policies. It would require insurers to provide full coverage for diagnostic and screening colonoscopies and related medically necessary preparation, shifting costs from patients to insurers and, indirectly, to premiums or plan design. The affected parties would include health insurers, policyholders, and health care providers who order or perform colonoscopy-related services.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the measure appears to be a straightforward health coverage mandate with an access-to-care rationale. The stated purpose suggests support for reducing financial barriers to colorectal cancer screening and diagnostic follow-up. No contrary viewpoints are documented in the supplied record, so the overall sentiment cannot be assessed beyond the bill’s pro-coverage framing.
Contention
No specific contention is documented in the provided transcripts or voting history, but bills of this type commonly raise concerns about insurance premium impacts, mandated-benefit expansion, and the scope of what counts as medically necessary preparation. Supporters would likely emphasize improved access to screening and early detection, while potential opponents may focus on added costs for insurers and employers sponsoring group coverage.